Rui Zhang

Rui Zhang

Auto-generated profile, based on publicly available information

Rui Zhang

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Traditional Chinese Medicine, Beijing 100010, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2022 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
MZMina Zhang
Mina Zhang
BLBo Lian
Bo Lian
RZRui Zhang
Rui Zhang
YGYuhong Guo
Yuhong Guo
JZJingxia Zhao
Jingxia Zhao
XXXiaolong Xu
Xiaolong Xu
Sepsis-induced inflammatory response leads to intestinal damage and secondary bacterial translocation, causing systemic infections and eventually death. Emodin is a natural anthraquinone derivative in many plants with promising bioactivities. However, the effects and mechanisms of emodin on sepsis-induced intestinal dysfunctions have not been well clarified yet. We found that emodin treatment suppressed the inflammatory response in the intestines of septic mice. Intestinal barrier function was also improved by emodin through enhancing ZO-1 and occludin expression, which prevented the secondary translocation of Escherichia coli. By proteome microarray investigation, JNK2 was identified as a direct target of emodin. In vitro study also showed that emodin inhibited LPS-induced inflammatory response in intestinal epithelial cells. Nuclear factors including NF-κB and AP-1 were further identified as downstream effectors of JNK2. Bioinformatic analysis based on 16s rRNA gene sequencing illustrated that emodin treatment significantly increased the alpha- and beta-diversity of gut microbiota in septic mice. Moreover, data according to functional prediction showed that emodin decreased the abundance of potential pathogenic bacteria in gut. Our findings have shown that emodin treatment prevented inflammatory induced barrier dysfunction and decreased the potential pathogenicity of lumen bacteria, reducing the hazard of lumen bacterial translocation during sepsis.

21 April 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
JHJing Hu
Jing Hu
SFShuo Feng
Shuo Feng
XZXiaoli Zhang
Xiaoli Zhang
HZHuina Zhang
Huina Zhang
YHYanxiang Ha
Yanxiang Ha
BLBo Li
Bo Li
Background. Multiple primary outcomes are commonly used in randomized controlled trials (RCTs) of Chinese herbal medicine (CHM). Analysis and interpretation of the results of CHM RCTs with many outcomes are not clear. No previous studies have systematically assessed the use of multiple primary outcomes in this area. This study aimed to assess the reporting of multiple primary outcomes and the statistical methods used to adjust multiplicity in RCTs of CHM. Methods. Search for RCTs of CHM published in English between January 2010 and December 2019 in MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials (CENTRAL) was undertaken. We randomly selected 20% of the included RCTs as the analyzing sample of this study. The number of multiple primary outcomes, the methods used to adjust the multiplicity in statistical analysis and sample size estimate, and the trial information were collected. For RCTs that adopted multiple primary outcomes without the multiplicity adjustment, we used Bonferroni correction to adjust. Results. 227 CHM RCTs were included in our study. 92 (40.5%) failed to report what their primary outcome was. Of 135 (59.5%) RCTs that reported primary outcome, 93 (68.9%) reported one and 42 (31.1%) reported more than one primary outcome (range 2–5). Of 42 RCTs that reported multiple primary outcomes, only 5 adjusted for multiple outcomes. If multiplicity had been accounted for using Bonferroni correction, 10 (37.0%) RCTs that reported a significant result had demonstrated a nonsignificant result, giving the adjusted P value. Only one of the 42 RCTs calculated sample size based on multiple primary outcomes. Adopting multiple primary outcomes showed a slow growth trend with the publication year. The proportion of primary outcome reported explicitly in RCTs was different in terms of the nationality of the first author ( ), in which mainland China has the lowest proportion (55.8%). The highest percentage of the studies with primary outcome reporting explicitation was mental and behavioural disorders (83.3%), and the most frequently adopting multiple primary outcomes were studies on the disease of the nervous system (66.7%). The percentage of reporting primary outcome explicitly was associated with sample size ( ); for the percentage of RCTs adopting multiple primary outcomes, there was no statistically significant difference ( ). Conclusions. Multiple primary outcomes are prevalent in CHM RCTs. However, appropriate methods are not usually taken in most of the analyses to safeguard the inferences against multiplicity. Sample size estimation based on multiple primary outcomes is still lacking. These issues complicate the interpretability of trial results and can lead to spurious conclusions. Guidelines to improve analyzing and reporting for multiple primary outcomes in CHM RCTs are warranted.

16 October 2020
Verified
Conference Paper
Closed access
QZQin Zhang
Qin Zhang
LWLisong Wang
Lisong Wang
HRHao Rong
Hao Rong
QGQingfan Gu
Qingfan Gu
YHYang Hong
Yang Hong
RZRui Zhang
Rui Zhang
Considering the dynamic characteristics of Integrated Modular Avionics (IMA) core processing system, such as fault-tolerant redundancy and sequence correlation, it is not enough to simply determine the results of different combinations of fault events, it is also necessary to understand the correlation of their failures. The Dynamic Fault Tree (DFT) analysis method is applied to the safety design of the IMA core processing system to ensure that the system design meets the safety requirements of aircraft. However, Dynamic Fault Tree Analysis (DFTA) requires a lot of manual effort, it will cause the state space explosion and low calculation accuracy, which makes it time-consuming and expensive. This paper presents a dynamic fault tree analysis based on Discrete-Time Bayesian Network (DTBN). Aimed at verifying the characteristics of the presented approach, we conduct a comparative experiment on the accuracy of calculating top events probability under DTBN method and Markov chain analysis method. Finally, we draw the conclusion that the DTBN method has higher accuracy and can effectively avoid space-and-state explosion at the same time.